Glypican-3, ALDH1A1, TNFR2, STAT3, FOXP3, and TIM3 are increasingly recognised biomarkers to predict chemoresistance in women with ovarian cancer. This evidence concerns the gene ALDH1A1 and ovarian carcinoma.